Using metabolomics with neonatal blood spots to discover ... · Yukiko Yano. Katie Hall. Courtney...

Post on 16-Jul-2020

0 views 0 download

Transcript of Using metabolomics with neonatal blood spots to discover ... · Yukiko Yano. Katie Hall. Courtney...

Using metabolomics with neonatal blood spots to discover causes of

childhood leukemia

S.M. Rappaport and Lauren PetrickUniversity of California, Berkeley

Known or suspected causes of childhood leukemia (mostly ALL)

• Genes (< 10% of risk)• Exposures

o Associations with radiation, paternal smoking and some environmental chemicals

• Early life exposures important o Identical twins diagnosed as infants have very

high concordance rateso Most ALLs diagnosed before age 5

Cancer Facts & Figures 2014: Special Addition, ACS

Age at diagnosis of CL

• Approximately 2,500 new cases per/year among children <15 years in the US

• Highest rates in Whites, Hispanics, and males

The blood exposome

S.M. Rappaport and M.T. Smith, Science, 2010: 330:460-461

EXPOSURES ARE CHEMICALS …and the blood exposome includes all chemicals in the body .

Exposures

Metabolome(Small molecules)

Transcriptome

Childhood leukemia

Genome

Lifestyle & infections

Diet & microbiome

Pollutants & radiation

EpigenomeProteome

Adductome(Reactive electrophiles)

Functional genome

Psychosocial stress

Chemical communicationFetal-blood exposome

Other factorsMaternal healthGender Birth weight

Archived neonatal dried blood spots (ANBS) contain information about the fetal exposome

Collected from 98% of newborns in the united states, 24-48 hours after birth

Used to test for congenital disorders If stored, can be used in

epidemiological studies Unique and important biospecimen

for understanding causes of pediatric disease

Untargeted metabolomics andadductomics

ANBS (4.7-mm punch ~ 8 µL blood)

Solvent extraction

Centrifugal filtration

Small molecules

Proteins (mostly HSA)

LC-HRMS

Digest

Add Int. Std.

Add Int. Std.

Trypsin

Lauren PetrickWill EdmandsHasmik GrigoryanKatie HallYukiko Yano

Scheme for performing exposomics with ANBS

LC-High resolution mass spectrometry

UPLC analysis

Sample

Will EdmandsLauren Petrick

Abun

danc

e

Retention Time (min)

urine MSMS

m/z60 80 100 120 140 160 180 200 220 240 260 280 300 320 340

%

0

100WE_urine_negMSMS020310c 7 (0.607) Cm (7:8) 2: TOF MSMS 303.02ES-

1.18e3151.0072

132.9966

96.950487.0106111.1543

153.0052

302.0393175.0368 191.0374 227.0531 261.0596347.0404

MASS SPECTRUM (MS/MS)

Small-molecule features ESI (-) mode

Detected 66,096

After filtering (fold change above background > 5) 8,852

Features with CV < 20% 3,919

Testable clusters 665

Small molecules in ANBS (100 CL cases & matched controls)

A glimpse of the fetal exposome

NucleotidePhosphateSulphateMS2-matched feature

Fatty acids

Steroids & hormones

Lipids

Microbial metabolites

Monosaccharides

Glutathione

Will Edmands

Tests of association with childhood leukemia (n =665 Features after filtering)

Machine learning algorithms (lasso & random forests) selected the same 7 discriminating molecules

Courtney SchiffmanLauren PetrickSandrine Dudoit

Findings• Seven small molecules in ANBS predict

childhood leukemia status in a learning sampleo Molecular identities are being confirmed

• Currently repeating analysis with a validation sample of ANBS (100 cases/100 controls)

ThanksHasmik Grigoryan

Will EdmandsYukiko Yano

Katie HallCourtney Schiffman

Sandrine DudoitAlan Hubbard

Catherine MetayerTodd Whitehead

Anthony Macherone (Agilent)Major support from NIEHS (U54ES016115, P01ES018172) & EPA (RD83451101)

Mass Spectrometry support from Agilent Technologies